UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in Mettler-Toledo International Inc. (NYSE:MTD) by 2.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 191,332 shares of the medical instruments supplier’s stock after selling 4,446 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Mettler-Toledo International were worth $286,941,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Mettler-Toledo International by 4.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,989 shares of the medical instruments supplier’s stock worth $8,982,000 after acquiring an additional 234 shares during the period. Glenmede Trust Co. NA lifted its position in Mettler-Toledo International by 2.2% in the third quarter. Glenmede Trust Co. NA now owns 1,155 shares of the medical instruments supplier’s stock valued at $1,732,000 after purchasing an additional 25 shares during the period. Townsquare Capital LLC boosted its holdings in Mettler-Toledo International by 2.0% in the 3rd quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock valued at $693,000 after purchasing an additional 9 shares in the last quarter. Brooklyn Investment Group acquired a new position in Mettler-Toledo International during the 3rd quarter worth approximately $118,000. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Mettler-Toledo International by 0.9% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 22,459 shares of the medical instruments supplier’s stock worth $33,680,000 after buying an additional 193 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,250.85 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,068.33 and a 1-year high of $1,546.93. The firm has a 50 day simple moving average of $1,345.17 and a 200-day simple moving average of $1,393.97. The stock has a market cap of $26.39 billion, a price-to-earnings ratio of 33.72, a price-to-earnings-growth ratio of 4.10 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. On average, equities analysts expect that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

MTD has been the subject of several research analyst reports. JPMorgan Chase & Co. increased their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Stifel Nicolaus cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Wells Fargo & Company dropped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Finally, Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,338.75.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.